These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9023383

  • 1. A comparison of the physiological effects of RSU1069 and RB6145 in the SCCVII murine tumour.
    Wood PJ, Horsman MR, Khalil AA, Steinberg F, Streffer C, Overgaard J, Stratford IJ, Adams GE.
    Acta Oncol; 1996; 35(8):989-94. PubMed ID: 9023383
    [Abstract] [Full Text] [Related]

  • 2. Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference to in vivo methods of evaluation.
    Bremner JC.
    Cancer Metastasis Rev; 1993 Jun; 12(2):177-93. PubMed ID: 8375020
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of bioreductive drug toxicity in murine tumours by inhibition of the activity of nitric oxide synthase.
    Butler SA, Wood PJ, Cole S, Williams C, Adams GE, Stratford IJ.
    Br J Cancer; 1997 Jun; 76(4):438-44. PubMed ID: 9275019
    [Abstract] [Full Text] [Related]

  • 4. Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.
    Bremner JC, Adams GE, Pearson JK, Sansom JM, Stratford IJ, Bedwell J, Bown SG, MacRobert AJ, Phillips D.
    Br J Cancer; 1992 Dec; 66(6):1070-6. PubMed ID: 1457346
    [Abstract] [Full Text] [Related]

  • 5. Comparing the anti-tumor effect of several bioreductive drugs when used in combination with photodynamic therapy (PDT).
    Bremner JC, Bradley JK, Adams GE, Naylor MA, Sansom JM, Stratford IJ.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):329-32. PubMed ID: 8195028
    [Abstract] [Full Text] [Related]

  • 6. Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.
    Horsman MR, Chaplin DJ, Hill SA, Arnold S, Collingridge D, Radacic M, Wood PJ, Overgaard J.
    Br J Cancer Suppl; 1996 Jul 15; 27():S168-71. PubMed ID: 8763873
    [Abstract] [Full Text] [Related]

  • 7. Bioreductive drugs and the selective induction of tumour hypoxia.
    Bremner JC, Stratford IJ, Bowler J, Adams GE.
    Br J Cancer; 1990 May 15; 61(5):717-21. PubMed ID: 2110814
    [Abstract] [Full Text] [Related]

  • 8. Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine.
    Wood PJ, Sansom JM, Butler SA, Stratford IJ, Cole SM, Szabo C, Thiemermann C, Adams GE.
    Cancer Res; 1994 Dec 15; 54(24):6458-63. PubMed ID: 7987843
    [Abstract] [Full Text] [Related]

  • 9. Tirapazamine administered as a neoadjuvant to radiotherapy reduces metastatic dissemination.
    Lunt SJ, Telfer BA, Fitzmaurice RJ, Stratford IJ, Williams KJ.
    Clin Cancer Res; 2005 Jun 01; 11(11):4212-6. PubMed ID: 15930359
    [Abstract] [Full Text] [Related]

  • 10. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069.
    Olive PL.
    Br J Cancer; 1995 Mar 01; 71(3):537-42. PubMed ID: 7880736
    [Abstract] [Full Text] [Related]

  • 11. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
    Twentyman PR, Workman P.
    Br J Cancer; 1983 Feb 01; 47(2):187-94. PubMed ID: 6824566
    [Abstract] [Full Text] [Related]

  • 12. Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
    Suit HD, Maimonis P, Michaels HB, Sedlacek R.
    Radiat Res; 1981 Aug 01; 87(2):360-7. PubMed ID: 7268001
    [No Abstract] [Full Text] [Related]

  • 13. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P, Workman P.
    Br J Cancer; 1982 Mar 01; 45(3):447-55. PubMed ID: 7073938
    [Abstract] [Full Text] [Related]

  • 14. Effect of angiotensin II on intermittent tumour blood flow and acute hypoxia in the murine SCCVII carcinoma.
    Trotter MJ, Chaplin DJ, Olive PL.
    Eur J Cancer; 1991 Mar 01; 27(7):887-93. PubMed ID: 1834122
    [Abstract] [Full Text] [Related]

  • 15. Tumor blood flow changes induced by chemical modifiers of radiation response.
    Chaplin DJ, Horsman MR.
    Int J Radiat Oncol Biol Phys; 1992 Mar 01; 22(3):459-62. PubMed ID: 1735678
    [Abstract] [Full Text] [Related]

  • 16. Pyruvate induces transient tumor hypoxia by enhancing mitochondrial oxygen consumption and potentiates the anti-tumor effect of a hypoxia-activated prodrug TH-302.
    Takakusagi Y, Matsumoto S, Saito K, Matsuo M, Kishimoto S, Wojtkowiak JW, DeGraff W, Kesarwala AH, Choudhuri R, Devasahayam N, Subramanian S, Munasinghe JP, Gillies RJ, Mitchell JB, Hart CP, Krishna MC.
    PLoS One; 2014 Mar 01; 9(9):e107995. PubMed ID: 25254649
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCCVII and KHT murine tumours.
    Fenton BM.
    Br J Cancer; 1995 May 01; 71(5):945-9. PubMed ID: 7734318
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors.
    Sørensen M, Horsman MR, Cumming P, Munk OL, Keiding S.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):854-61. PubMed ID: 15936570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.